Chikungunya
Chikungunya virus (CHIKV) is a viral infection that is primarily transmitted to humans through the bite of infected mosquitoes, particularly Aedes aegypti and Aedes albopictus species. It belongs to the genus Alphavirus, which is a part of the Togaviridae family.
The symptoms of chikungunya typically develop 2 to 7 days after being bitten by an infected mosquito. Common symptoms include fever, severe joint pain, muscle pain, headache, rash, fatigue, and swelling of the joints. The joint pain associated with chikungunya infection can be debilitating and may persist for weeks or months, leading to prolonged discomfort and impaired mobility.
While chikungunya is rarely fatal, it can cause significant morbidity and impact the quality of life of affected individuals. There is no specific antiviral treatment for chikungunya, so management mainly focuses on relieving the symptoms. Pain relievers, anti-inflammatory medications, and plenty of rest are usually recommended.
This magazine contains content which is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Chikungunya Virus.
-
Publication date: Nov 30, 2023 Mosquito research in Europe has a long history, primarily focused ...
-
FDA Approves First Chikungunya Vaccine.
Publication date: Nov 29, 2023 Open Access PDF Concepts Keywords Approves Approves Chikungunya Chikungunya Clinical ... -
Mitochondrial protein BNIP3 regulates Chikungunya virus replication in the early stages of infection.
Publication date: Nov 27, 2023 Chikungunya virus (CHIKV) is a human pathogen causing outbreaks of ... -
Evaluating the Effectiveness of Pisonia alba Leaf Extracts in Managing Aedes aegypti and Culex quinquefasciatus Populations via Larvicidal, Pupicidal and Ovicidal Actions.
Publication date: Nov 24, 2023 The purpose of this study was to evaluate the effectiveness ... -
Mayaro virus pathogenesis and immunity in rhesus macaques.
Publication date: Nov 20, 2023 Mayaro virus (MAYV) is a mosquito-transmitted alphavirus that causes debilitating ... -
Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform.
Publication date: Nov 21, 2023 Reverse genetic systems enable the engineering of RNA virus genomes ... -
The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection.
Publication date: Nov 16, 2023 Alphaviruses are a large group of re-emerging arthropod-borne RNA viruses. ... -
The Evil DExH/D: Chikungunya virus runs but cannot hide from DDX39A.
Publication date: Nov 16, 2023 In this issue, Tapescu et al. identify DDX39A as a ... -
Viral infections and pathogenesis of glaucoma: a comprehensive review.
Publication date: Nov 15, 2023 SUMMARYGlaucoma is a leading cause of irreversible blindness worldwide, caused ... -
Clinical, epidemiological, and molecular investigation of Kyasanur forest disease from Karnataka state, India during 2018-2019.
Publication date: Nov 15, 2023 In this study, we carried out an investigation of Kyasanur ... -
“What will the doctor give me, the same painkiller?”: a qualitative study exploring health-care seeking and symptoms self-management among patients for the treatment of long-term chikungunya disease, in Curaçao.
Publication date: Nov 13, 2023 Long-term chikungunya disease, characterized by persistent disabling rheumatic symptoms, including ... -
Joint Involvement Can Predict Chikungunya in a Dengue Syndemic Setting in India.
Publication date: Nov 14, 2023 Dengue and chikungunya have been endemic in India but have ... -
Novel strains of Culex flavivirus and Hubei chryso-like virus 1 from the Anopheles mosquito in western Kenya.
Publication date: Nov 07, 2023 Surveillance of mosquito vectors is critical for early detection, prevention ... -
One receptor, two worlds: MXRA8’s alphavirus tango.
Publication date: Nov 08, 2023 Mammalian MXRA8 functions as a receptor for chikungunya and other ... -
Statistical modeling for identifying chikungunya high-risk areas of two large-scale outbreaks in Thailand’s southernmost provinces.
Publication date: Nov 03, 2023 Chikungunya fever (CHIKF) has re-emerged in the southernmost Thailand and ... -
Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies.
Publication date: Oct 17, 2023 The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection drove the global ... -
Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO.
Publication date: Oct 13, 2023 Infection with chikungunya virus (CHIKV) causes disruption of draining lymph ... -
Dehydration induced AePer50 regulates midgut infection in Ae. aegypti.
Publication date: Oct 12, 2023 In the face of climate change, mosquitoes will experience evolving ... -
Allergies, body mass, and hospitalization due to arbovirus infection: A prospective surveillance study in Machala, Ecuador.
Publication date: Oct 12, 2023 Dengue, chikungunya, and Zika are arboviruses that cause 390 million ... -
Does a patient with acquired arbovirus infection have a hearing impairment? A scoping review of hearing changes in an adult with Dengue, Chikungunya, and Zika.
Publication date: Oct 11, 2023 To identify and understand the evidence regarding hearing changes related ... -
Potential Global Distribution of the Invasive Mosquito Aedes koreicus under a Changing Climate.
Publication date: Oct 10, 2023 Invasive alien species are a growing threat to natural systems, ...